Skip to content

Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors

Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05417451
Enrollment
46
Registered
2022-06-14
Start date
2021-11-01
Completion date
2025-02-26
Last updated
2025-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The objectives of this study to explore whether acupuncture can improve the psychoneurological symptom cluster (pain, fatigue, sleep disturbance) in survivors of breast cancer and explore biomarker changes after the acupuncture intervention. Acupuncture treatments will be provided to breast cancer survivors twice weekly for 5 weeks.

Detailed description

The investigators will conduct the study with early stage breast cancer survivors who have completed their primary cancer treatment. They will all receive acupuncture. Treatments will be twice weekly for 5 weeks, for 30 minutes per treatment. At baseline and post-treatment, subjects will be collected blood and stool samples, complete symptom questionnaires that measure pain, fatigue, and sleep disturbance.

Interventions

OTHERAcupuncture

All participants will receive a semi-standardized acupuncture protocol (standardized points for pain, fatigue, depression, anxiety, sleep disturbance, with additional points for patient's particular pain location)

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women with histologically confirmed stage 0, I, II, or III breast cancer * who have completed their primary cancer treatment (e.g., surgery, radiotherapy, chemotherapy) at least 3 months prior and within 5 years * are currently receiving adjuvant endocrine therapy * are able to read and speak English * with self-reported pain, fatigue, sleep disturbance in the last three months and their worst severity rating ≥ 3 (0-10 numeric rating scale) for at least two of the three symptoms

Exclusion criteria

* have self-reported hospitalization for psychiatric illness within the past 2 years * have a bleeding disorder * physically or cognitively unable to complete the study procedures * pregnant women

Design outcomes

Primary

MeasureTime frameDescription
PROMIS Pain InterferenceAfter 10th acupuncture treatment, at 6 weeks post-baseline (study completion)Scores range from 4-20; higher scores indicate that pain is interfering with daily activities more
PROMIS FatigueAfter 10th acupuncture treatment, at 6 weeks post-baseline (study completion)Scores range from 4-20; higher scores indicate that severe fatigue
PROMIS Sleep DisturbanceAfter 10th acupuncture treatment, at 6 weeks post-baseline (study completion)Scores range from 4-20; higher scores indicate that severe sleep disturbance

Secondary

MeasureTime frameDescription
PROMIS DepressionAfter 10th acupuncture treatment, at 6 weeks post-baseline (study completion)Scores range from 4-20; higher scores indicate that severe depression
PROMIS AnxietyAfter 10th acupuncture treatment, at 6 weeks post-baseline (study completion)Scores range from 4-20; higher scores indicate that severe anxiety

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026